Last reviewed · How we verify
NCT04234490
Longitudinal Evaluation of the Impact of Parenteral Nutrition
trial testing Parenteral nutrition in Parenteral Nutrition in 912 participants. Completed in 23 March 2022.
23 March 2022
Quick facts
| Lead sponsor | University of Manchester |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 912 |
| Start date | 2 March 2020 |
| Primary completion | 23 March 2022 |
| Estimated completion | 23 March 2022 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Parenteral nutrition — full drug profile →
Conditions studied
- Parenteral Nutrition — all drugs for Parenteral Nutrition →
Sponsor
University of Manchester
Who can join
18 and older, any sex, with Parenteral Nutrition. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients with type 3 intestinal failure are completely reliant on artificial feeding and often manage this at home; home parenteral nutrition (HPN). HPN therapy is life saving for these patients. The Parenteral Nutrition Impact Questionnaire (PNIQ) is a proven tool for measuring quality of life when receiving HPN. This study will recruit HPN patients across the United Kingdom (UK) and ask them to complete the PNIQ survey at several different time points. This will assess the impact of HPN over time. Family members involved in the participants HPN care will also be asked to complete a carer burden survey (at one time point) to assess the impact of HPN on carers.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04234490
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Parenteral nutrition
Trials testing the same drug.
- NCT03742752 — Enteral Versus Parenteral Nutrition in the Conservative Treatment of Upper Gastrointestinal Fistula After Surgery · NA · terminated
- NCT03767634 — Outcomes Following Early Parenteral Nutrition Use in Preterm Neonates · completed
- NCT04456647 — Parenteral Nutrition Therapy in Patients With Incurable Cancer · completed
- NCT03411447 — Impact of Early Enteral vs. Parenteral Nutrition on Risk of Gastric-Content Aspiration in Patients Requiring Mechanical · NA · terminated
- NCT02066363 — Study of Parenteral Nutrition to Patients With Gastrointestinal Cancer · NA · terminated
Other recruiting trials for Parenteral Nutrition
Currently open trials in the same condition.
- NCT06625957 — Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral Nutrition · Phase 3 · recruiting
- NCT06510348 — Achieving nuTritional Target in criticAlly Ill patieNts With iMpairEd gastroiNtesTinal Dysfunction · NA · recruiting
- NCT06525753 — Weaning is Winning? (WeWin Study) · recruiting
Other University of Manchester trials
Trials by the same sponsor.
- NCT07506096 — Using IF-THEN Plans to Support Healthcare Professionals in Raising Patient Safety Concerns · NA · not yet recruiting
- NCT07084090 — Using IF-THEN Plans to Support Patients in Raising Safety Concerns About Their Care · NA · not yet recruiting
- NCT07494760 — A Feasibility Randomised Control Trial to Evaluate Early Perinatal Bereavement Counselling for Parents Who Have Experien · NA · not yet recruiting
- NCT07372885 — GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmia · Phase 1, PHASE2 · not yet recruiting
- NCT07381894 — Multicentre Hypertrophic Cardiomyopathy Registry · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04234490 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Manchester
- Last refreshed: 24 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04234490.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing